Certara Inc (CERT) Stock Price, Quote & News

Company Profile

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharm...

Industry: Health Information Services

Sector: Healthcare

Phone: 415 237 8272

Website: www.certara.com

Address:

4 Radnor Corporate Center, Suite 350, Radnor, United States

IDrawLiness Apr. 23 at 11:52 PM

$ILMN BioAI - Carl Icahn has been buying recently.. $CERT simulates what the drug might do, ILMN does the research.. market will shine a spotlight here soon IMO

0 · Reply

IDrawLiness Apr. 23 at 11:27 PM

$CERT bottom? biosimulation area, not my strong area but hedge funds did a good job buying up shares through 2025.. recent insider buying..

0 · Reply

OfficialStocktwitsUser Apr. 23 at 1:32 AM

$CERT RSI: 78.57, MACD: -0.0679 Vol: 0.33, MA20: 5.83, MA50: 6.36 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BigDaddyCapital Apr. 1 at 1:52 PM

$CERT this is getting dirt cheap

0 · Reply

DonCorleone77 Mar. 7 at 5:18 PM

$CERT Certara price target lowered to $10 from $15 at UBS UBS lowered the firm's price target on Certara to $10 from $15 and keeps a Buy rating on the shares. The firm says the company's Q4 results and 2026 guidance challenge the Buy thesis on the shares. Certara reported a Q4 services miss and deceleration in software bookings, the analyst tells investors in a research note. However, UBS believes the company remains "uniquely positioned" in model-informed drug development.

0 · Reply

BillionerOfKing Mar. 5 at 12:03 AM

$CERT Current Stock Price: $7.35 Contracts to trade: $7.5 CERT Mar 20 2026 Call Entry: $0.05 Exit: $0.07 ROI: 49% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

OfficialStocktwitsUser Feb. 27 at 2:47 AM

$CERT RSI: 33.33, MACD: -0.6142 Vol: 0.80, MA20: 7.17, MA50: 8.42 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

briefingcom Feb. 26 at 1:26 PM

$CERT: Certara misses by $0.02, reports revs in-line; guides FY26 EPS below consensus, revs below consensus https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260226060523CERT&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

0 · Reply

BigDaddyCapital Feb. 26 at 12:03 PM

$CERT company bought back shares this quarter

0 · Reply

StocktwitsEarnings Feb. 26 at 11:31 AM

$CERT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.04 down -200.00% YoY • Reported revenue of $103.65M up 3.28% YoY • Certara expects full year 2026 revenue growth of 0-4%, an adjusted EBITDA margin of approximately 30-32%, and adjusted diluted EPS in the range of $0.44-$0.48.

0 · Reply

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst

Apr 22, 2026, 7:00 AM EDT - 7 days ago

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Apr 22, 2026, 7:00 AM EDT - 7 days ago

Veristat to Acquire Certara's Regulatory and Medical Writing Business

Apr 9, 2026, 4:15 PM EDT - 20 days ago

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

Mar 10, 2026, 1:00 PM EDT - 7 weeks ago

Certara Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 9, 2026, 8:00 AM EDT - 7 weeks ago

Certara Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 3:10 PM EST - 2 months ago

Certara Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 8:00 AM EST - 2 months ago

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Feb 27, 2026, 8:30 AM EST - 2 months ago

Certara to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:30 AM EST - 2 months ago

Certara Earnings Call Transcript: Q4 2025

Feb 26, 2026, 6:00 AM EST - 2 months ago

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

Feb 3, 2026, 6:23 AM EST - 3 months ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

VVOS ZLAB

Jan 29, 2026, 8:30 AM EST - 3 months ago

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025

Dec 31, 2025, 10:57 AM EST - 4 months ago

Tax-related selling could set up these 11 stocks for big gains early in 2026

CNH CNS COTY FRSH GOGO JJSF KNTK

Dec 11, 2025, 6:00 AM EST - 4 months ago

Certara Appoints Jon Resnick as Chief Executive Officer

Nov 18, 2025, 2:00 PM EST - 5 months ago

Certara Transcript: Stephens Annual Investment Conference

Nov 18, 2025, 5:30 AM EST - 5 months ago

Certara Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

Certara Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:15 PM EST - 6 months ago

Certara Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 8:00 AM EST - 6 months ago

Certara Automates Scientific Workflows with Phoenix® Cloud

Oct 30, 2025, 4:15 PM EDT - 6 months ago

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Oct 20, 2025, 8:00 AM EDT - 6 months ago

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Oct 10, 2025, 8:00 AM EDT - 7 months ago

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Sep 23, 2025, 6:34 PM EDT - 7 months ago

Final Trade: CERT, GDX, IWM, MPC

GDX IWM MPC

Sep 10, 2025, 12:20 PM EDT - 8 months ago

Certara Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 10:15 AM EDT - 8 months ago

Certara Transcript: Baird Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 8 months ago

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Aug 6, 2025, 5:00 PM EDT - 9 months ago

Certara Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:15 PM EDT - 9 months ago

Certara Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 2:00 AM EDT - 9 months ago

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Jul 31, 2025, 4:15 PM EDT - 9 months ago

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Jul 9, 2025, 4:15 PM EDT - 10 months ago

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Jul 8, 2025, 8:00 AM EDT - 10 months ago

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Jun 4, 2025, 1:40 PM EDT - 11 months ago

Certara Transcript: 45th Annual William Blair Growth Stock Conference

May 13, 2025, 6:40 PM EDT - 1 year ago

Certara Transcript: Bank of America 2025 Healthcare Conference

May 5, 2025, 5:00 PM EDT - 1 year ago

Certara Earnings Call Transcript: Q1 2025

May 5, 2025, 4:15 PM EDT - 1 year ago

Certara Reports First Quarter 2025 Financial Results

Apr 14, 2025, 2:08 PM EDT - 1 year ago

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Apr 14, 2025, 8:15 AM EDT - 1 year ago

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Apr 11, 2025, 10:44 AM EDT - 1 year ago

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

CRL SLP

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Mar 12, 2025, 11:30 AM EDT - 1 year ago

Certara Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 4:15 PM EST - 1 year ago

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Feb 26, 2025, 5:00 PM EST - 1 year ago

Certara Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:15 PM EST - 1 year ago

Certara Reports Fourth Quarter 2024 Financial Results

Jan 29, 2025, 4:15 PM EST - 1 year ago

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Jan 15, 2025, 8:15 PM EST - 1 year ago

Certara Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:55 AM EST - 1 year ago

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 10, 2025, 7:14 PM EST - 1 year ago

Final Trade: CERT, XLE, DAL, OKTA

OKTA XLE DAL

Jan 2, 2025, 4:15 PM EST - 1 year ago

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 2, 2024, 4:15 PM EST - 1 year ago

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Nov 21, 2024, 11:00 AM EST - 1 year ago

Certara Transcript: Stephens 26th Annual Investment Conference | NASH2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Certara Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:15 PM EST - 1 year ago

Certara Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 4:15 PM EDT - 1 year ago

Certara to Participate in the Stephens Annual Investment Conference

Oct 16, 2024, 4:15 PM EDT - 1 year ago

Certara Appoints John Reynders as New Independent Board Member

Oct 9, 2024, 4:15 PM EDT - 1 year ago

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Oct 2, 2024, 4:15 PM EDT - 1 year ago

Certara Completes Acquisition of Chemaxon

Sep 27, 2024, 6:37 PM EDT - 1 year ago

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

KNX LULU NEE

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Sep 11, 2024, 10:15 AM EDT - 1 year ago

Certara Transcript: The Baird 2024 Global Healthcare Conference

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Certara Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 15, 2024, 4:15 PM EDT - 1 year ago

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Aug 6, 2024, 5:00 PM EDT - 1 year ago

Certara Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:15 PM EDT - 1 year ago

Certara Reports Second Quarter 2024 Financial Results

Jul 9, 2024, 4:45 PM EDT - 1 year ago

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Jul 2, 2024, 4:15 PM EDT - 1 year ago

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

Jun 17, 2024, 8:00 AM EDT - 2 years ago

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

Jun 5, 2024, 11:30 AM EDT - 2 years ago

Certara Transcript: Jefferies Global Healthcare Conference

May 29, 2024, 4:15 PM EDT - 2 years ago

Certara to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 8:00 AM EDT - 2 years ago

Certara Appoints New Chief Human Resources Officer & General Counsel

May 14, 2024, 6:40 PM EDT - 2 years ago

Certara Transcript: BofA Securities Health Care Conference 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

Certara Earnings Call Transcript: Q1 2024

May 7, 2024, 4:15 PM EDT - 2 years ago

Certara Reports First Quarter 2024 Financial Results

Mar 13, 2024, 1:05 PM EDT - 2 years ago

Certara Transcript: Barclays 26th Annual Global Healthcare Conference

Feb 29, 2024, 5:00 PM EST - 2 years ago

Certara Earnings Call Transcript: Q4 2023

Nov 15, 2023, 3:00 PM EST - 2 years ago

Certara Transcript: Stephens Annual Investment Conference | NASH 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Certara Earnings Call Transcript: Q3 2023

Sep 13, 2023, 3:45 PM EDT - 2 years ago

Certara Transcript: Baird's Global Healthcare Conference 2023

Sep 12, 2023, 5:30 PM EDT - 2 years ago

Certara Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Aug 9, 2023, 5:00 PM EDT - 2 years ago

Certara Earnings Call Transcript: Q2 2023

May 10, 2023, 11:40 AM EDT - 3 years ago

Certara Transcript: Bank of America Global Healthcare Conference 2023

May 8, 2023, 5:00 PM EDT - 3 years ago

Certara Earnings Call Transcript: Q1 2023

Mar 15, 2023, 11:15 AM EDT - 3 years ago

Certara Transcript: Barclays Global Healthcare Conference

Mar 1, 2023, 5:00 PM EST - 3 years ago

Certara Earnings Call Transcript: Q4 2022

Nov 15, 2022, 11:30 AM EST - 3 years ago

Certara Transcript: Jefferies London Healthcare Conference

Nov 7, 2022, 8:15 AM EST - 3 years ago

Certara Earnings Call Transcript: Q3 2022

Sep 14, 2022, 6:15 AM EDT - 3 years ago

Certara Transcript: Baird 2022 Global Healthcare Conference

Aug 9, 2022, 5:00 PM EDT - 4 years ago

Certara Earnings Call Transcript: Q2 2022

May 5, 2022, 5:00 PM EDT - 4 years ago

Certara Earnings Call Transcript: Q1 2022

Mar 1, 2022, 5:00 PM EST - 4 years ago

Certara Earnings Call Transcript: Q4 2021

Dec 15, 2021, 3:00 PM EST - 4 years ago

Certara Transcript: Investor Day 2021

Nov 9, 2021, 5:00 PM EST - 4 years ago

Certara Earnings Call Transcript: Q3 2021

Aug 5, 2021, 5:00 PM EDT - 5 years ago

Certara Earnings Call Transcript: Q2 2021

May 6, 2021, 5:00 PM EDT - 5 years ago

Certara Earnings Call Transcript: Q1 2021

Mar 4, 2021, 5:00 PM EST - 5 years ago

Certara Earnings Call Transcript: Q4 2020

IDrawLiness Apr. 23 at 11:52 PM

$ILMN BioAI - Carl Icahn has been buying recently.. $CERT simulates what the drug might do, ILMN does the research.. market will shine a spotlight here soon IMO

0 · Reply

IDrawLiness Apr. 23 at 11:27 PM

$CERT bottom? biosimulation area, not my strong area but hedge funds did a good job buying up shares through 2025.. recent insider buying..

0 · Reply

OfficialStocktwitsUser Apr. 23 at 1:32 AM

0 · Reply

BigDaddyCapital Apr. 1 at 1:52 PM

$CERT this is getting dirt cheap

0 · Reply

DonCorleone77 Mar. 7 at 5:18 PM

0 · Reply

BillionerOfKing Mar. 5 at 12:03 AM

0 · Reply

OfficialStocktwitsUser Feb. 27 at 2:47 AM

0 · Reply

briefingcom Feb. 26 at 1:26 PM

0 · Reply

BigDaddyCapital Feb. 26 at 12:03 PM

$CERT company bought back shares this quarter

0 · Reply

StocktwitsEarnings Feb. 26 at 11:31 AM

0 · Reply

TradeStrider Feb. 18 at 10:13 AM

$CERT Auto logistics platform benefiting from digital adoption.

0 · Reply

Estimize Feb. 10 at 9:00 PM

Wall St is expecting 0.14 EPS for $CERT Q1 [Reporting 05/11 AMC] http://www.estimize.com/intro/cert?chart=historical&metric_name=eps&utm_co

0 · Reply

LongTermLens Feb. 4 at 2:18 PM

$CERT is a provider of enterprise software for identity and access management; it operates in the competitive cybersecurity market and must demonstrate consistent growth.

1 · Reply

BigDaddyCapital Feb. 2 at 8:46 PM

$CERT biggest PoS company on the market

0 · Reply

Crom5775 Jan. 27 at 1:20 PM

$CERT Keeping above its SymmetricalTriangle breakout. 50 day moving has started to curl up. Looks like a bull flag is setting up.

0 · Reply

BillionerOfKing Jan. 21 at 3:01 AM

$CERT Current Stock Price: $9.50 Contracts to trade: $10 CERT Feb 20 2026 Call Entry: $0.05 Exit: $0.07 ROI: 36% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

stockingu Jan. 14 at 3:01 PM

$PRSU, $CERT , $CRWV , $CRCL

0 · Reply

OfficialStocktwitsUser Jan. 13 at 8:24 PM

$CERT RSI: 51.55, MACD: 0.0287 Vol: 0.30, MA20: 9.05, MA50: 9.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ItoLemmaI Dec. 26 at 3:51 PM

$CERT Expectations are recalibrating toward pragmatic delivery instead of lofty projections. Efficiency initiatives must translate into measurable productivity. Overextension would degrade optionality during downturns. The trajectory strengthens as results compound visibly.

0 · Reply

Market Cap	941.42M
Revenue (ttm)	418.84M
Net Income (ttm)	-1.60M
EPS (ttm)	N/A
PE Ratio	23.11
Forward PE	21.52
Profit Margin	-0.38%
Debt to Equity Ratio	0.28

Volume	2,544,000
Avg Vol	3,849,506
Day's Range	N/A - N/A
Shares Out	153.33M
Stochastic %K	9%
Beta	1.62
Analysts	Sell
Price Target	$8.82